124 related articles for article (PubMed ID: 29722125)
1. Sample size determination and treatment screening in two-stage phase II clinical trials via ROC curve.
Huang WS; Chang YI
Pharm Stat; 2018 Sep; 17(5):504-514. PubMed ID: 29722125
[TBL] [Abstract][Full Text] [Related]
2. A flexible multi-stage design for phase II oncology trials.
Tan MT; Xiong X
Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
[TBL] [Abstract][Full Text] [Related]
3. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
4. A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development.
Chen C; Anderson K; Mehrotra DV; Rubin EH; Tse A
Contemp Clin Trials; 2018 Jan; 64():238-242. PubMed ID: 28966137
[TBL] [Abstract][Full Text] [Related]
5. A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials.
Jin H; Wei Z
Contemp Clin Trials; 2012 Nov; 33(6):1255-60. PubMed ID: 22772088
[TBL] [Abstract][Full Text] [Related]
6. Adaptive two-stage designs in phase II clinical trials.
Banerjee A; Tsiatis AA
Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
[TBL] [Abstract][Full Text] [Related]
7. An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure.
Taylor DJ; Grobler A; Abdool Karim SS
Clin Trials; 2012 Aug; 9(4):377-84. PubMed ID: 22610168
[TBL] [Abstract][Full Text] [Related]
8. Curtailed two-stage designs with two dependent binary endpoints.
Chen CM; Chi Y
Pharm Stat; 2012; 11(1):57-62. PubMed ID: 22162348
[TBL] [Abstract][Full Text] [Related]
9. Optimal planning of phase II/III programs for clinical trials with multiple endpoints.
Kieser M; Kirchner M; Dölger E; Götte H
Pharm Stat; 2018 Sep; 17(5):437-457. PubMed ID: 29700949
[TBL] [Abstract][Full Text] [Related]
10. Adaptive designs for single-arm phase II trials in oncology.
Englert S; Kieser M
Pharm Stat; 2012; 11(3):241-9. PubMed ID: 22411839
[TBL] [Abstract][Full Text] [Related]
11. Two-stage phase II oncology designs using short-term endpoints for early stopping.
Kunz CU; Wason JM; Kieser M
Stat Methods Med Res; 2017 Aug; 26(4):1671-1683. PubMed ID: 26037529
[TBL] [Abstract][Full Text] [Related]
12. Optimal two-stage randomized phase II clinical trials.
Logan BR
Clin Trials; 2005; 2(1):5-12. PubMed ID: 16279574
[TBL] [Abstract][Full Text] [Related]
13. Flexible designs for phase II comparative clinical trials involving two response variables.
Bersimis S; Sachlas A; Papaioannou T
Stat Med; 2015 Jan; 34(2):197-214. PubMed ID: 25274584
[TBL] [Abstract][Full Text] [Related]
14. Optimal adaptive two-stage designs for early phase II clinical trials.
Shan G; Wilding GE; Hutson AD; Gerstenberger S
Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
[TBL] [Abstract][Full Text] [Related]
15. Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies.
Wilson DT; Walwyn RE; Brown J; Farrin AJ; Brown SR
Stat Methods Med Res; 2016 Jun; 25(3):997-1009. PubMed ID: 26071430
[TBL] [Abstract][Full Text] [Related]
16. Stochastically curtailed phase II clinical trials.
Ayanlowo AO; Redden DT
Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
[TBL] [Abstract][Full Text] [Related]
17. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
18. Graphical search for two-stage designs for phase II clinical trials.
Jung SH; Carey M; Kim KM
Control Clin Trials; 2001 Aug; 22(4):367-72. PubMed ID: 11514038
[TBL] [Abstract][Full Text] [Related]
19. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
20. Exact two-stage designs for phase II activity trials with rank-based endpoints.
Wilding GE; Shan G; Hutson AD
Contemp Clin Trials; 2012 Mar; 33(2):332-41. PubMed ID: 22074983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]